# InMed Pharmaceuticals Inc.: Form 8-K, filed Mar 6, 2026

- Company: [InMed Pharmaceuticals Inc.](/companies/inm.md) (CIK 1728328)
- Form: 8-K
- Filed: 2026-03-06
- Accepted by EDGAR: Mar 6, 2026, 16:58 ET
- Period: 2026-03-04
- Accession: 0001213900-26-024752
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1728328/000121390026024752/ea0279869-8k_inmed.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1728328/000121390026024752/

## Items reported

- Item 2.05: Exit or disposal costs
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1728328/000121390026024752/ea0279869-8k_inmed.htm

Filed Mar 6, 2026.
Source: SEC EDGAR, the filing index for accession 0001213900-26-024752. Last ingested by Listed: Oct 29, 2026, 04:34 ET. No prices; not investment advice.